Molecular Templates Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Nov 30, 2022 / 02:15PM GMT
Jonathan Miller - Evercore ISI - Analyst

Good morning, everybody, and welcome to our chat with Eric from Molecular Templates. Thanks so much for joining us again for another year of this conference, Eric. I'd love to start with -- well, let's start with a little intro from you. I think you've got multiple programs in the clinic right now, a lot of irons in the fire and some interesting initial clinical activity. So how do you view Molecular Templates going forward into the next year?

Questions and Answers:

Eric Poma - Molecular Templates, Inc. - CEO & Chief Scientific Officer

Yeah. First, thanks again for the invite. This is always the best conference of the year, so my appreciations.

Jonathan Miller - Evercore ISI - Analyst

Say that to all the sell-siders, I'm sure.

Eric Poma - Molecular Templates, Inc. - CEO & Chief Scientific Officer

Sure. Look, I think it's been a good year for us. I think we have three drugs in the clinic that are either through Phase 1
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot